Gilead Sciences Announces Fourth Quarter and Full Year 2021 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Gilead Sciences (GILD) Misses Q4 EPS by 83c; Offers 2022 Guidance
February 1, 2022 4:04 PM ESTGilead Sciences (NASDAQ: GILD) reported Q4 EPS of $0.69, $0.83 worse than the analyst estimate of $1.52. Revenue for the quarter came in at $7.2 billion versus the consensus estimate of $6.51 billion.
GUIDANCE:
Gilead Sciences sees FY2022 EPS of $6.20-$6.70, versus the consensus of... More
